Apr 24, 2018 06:00 am UTC| Business
200 KOLs and surgeons trained across the U.S. and Europe to date Objective is to continue training a maximum of surgeons before the official launch of HEMOBLAST Bellows in mid-2018 NEW YORK and SAINT-PRIEST, France,...
Apr 24, 2018 06:00 am UTC| Business
Development of a gene therapy product for the treatment of patients with Fragile X syndromeImplementation of the project through a unique partnershipFirst results anticipated in 2019 CAMBRIDGE, Mass. and PARIS,...
Sanofi Head of Global R&D Elias Zerhouni to retire; Company names John Reed to take over on July 1
Apr 24, 2018 05:31 am UTC| Business
Press ReleaseSource: Sanofi (EURONEXT: SAN) (NYSE: SNY) Sanofi Head of Global RD Elias Zerhouni to retire; Company names John Reed to take over on July 1 Paris - 24th April 2018 -- Elias Zerhouni, M.D., Head of...
Apr 24, 2018 05:01 am UTC| Business
REGULATED INFORMATION GHENT, Belgium, 24 April 2018 - Ablynx [Euronext Brussels and Nasdaq: ABLX] today announced, in accordance with Article 14 of the Belgian Law of 2 May 2007 regarding the publication of major...
Targovax ASA: Invitation to first quarter 2018 results presentation Thursday 3 May
Apr 24, 2018 05:01 am UTC| Business
Oslo, Norway, 24 April 2018 - Targovax ASA (OSE: TRVX), a clinical stage company focused on developing immuno-oncology therapies to target solid tumors, will announce its first quarter 2018 results on Thursday, 3 May 2018....
MDxHealth Provides First Quarter 2018
Apr 24, 2018 05:01 am UTC| Business
NEWS RELEASE REGULATED INFORMATION ...
Apr 24, 2018 05:01 am UTC| Business
Eight-week follow-up data show separation of clinical efficacy scores between treatment group and placebo group through the duration of study Total and pathogenic IgG reduction correlates with disease score improvements ...